Affiliation:
1. National Medical Research Center of Oncology, Ministry of Health of Russia
2. Regional Consultative and Diagnostic Center
Abstract
Relevance. Ewingʼs sarcoma (ES) is a classic representative of the extensive family of ES tumors, which occupies one of the leading positions among the malignant pathology of the musculoskeletal system in children and adolescents. This group is characterized by an extremely large variety of morphological, immunohistochemical, and molecular genetic characters among its representatives. The absence of specific pathognomonic markers for ES, as well as the presence of wide variability of clinical manifestations complicates the differential diagnosis. Materials and methods. The study included patients of childhood and adolescence with a localized and generalized form of ES/PNEТ of various localizations undergoing treatment in the conditions of the Department of Pediatric Oncology of the Federal State Budgetary Research Center for Oncology from 2009 to 2019. As the material, the tissue of the primary tumor of ES/PNEТ from paraffin blocks was used, obtained from 67 patients during the primary biopsy, as well as after the surgical stage as part of a combined or complex treatment. The expression of ZEB1 was determined immunohistochemically.Results. The highest average level of expression of ZEB1 protein was observed in group 4 with a generalized form of ES (surgical material) and amounted to 60.8 ± 2.2 %, the minimum level was detected in group 2 with a localized form of ES (surgical material) and amounted to 29.2 ± 3.0 %. Between groups 2 (localized form) and 4 (generalized form) statistically significant differences were noted (p = 0.026).Conclusion. As a result of an immunohistochemical study, the ZEB1 protein showed its prognostic significance when comparing groups with a localized and generalized form of ES (p = 0.026). The predominance of the expression level of ZEB1 protein in the group with the generalized form statistically significantly increased the chances of metastasis by 3.6 times (95 % CI 1.13-11.8).
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference22 articles.
1. Samburova N.V., Pimenov I.A., Zhevak T.N., Litvickiy P.F. Ewingʼs sarcoma: molecular genetic mechanisms of pathogenesis. Voprosy Sovremennoy Pediatrii = Current Pediatrics 2019;18(4):257–63. (In Russ.). doi: 10.15690/vsp.v18i4.2042.
2. Semenova A.I. Ewingʼs sarcoma: disease characteristics, diagnostic features, therapeutic tactics. Prakticheskaya Onkologiya = Practical Oncology 2010;11(1):45. (In Russ.).
3. Bulanov D.V. Malignant small round cellular tumors of the Ewing sarcoma family: modern ideas on histogenesis, immunohistochemical, and molecular genetic markers. Molekulyarnaya meditsina = Molecular Medicine 2013;1:12–14.(In Russ.).
4. Chaturvedi A., Hoffman L.M., Jensen C.C., Lin Y.C., Grossmann A.H., Randall R.L., Lessnick S.L., Welm A.L., Beckerle M.C. Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma. Mol Biol Cell 2014;25(18):2695–709. doi: 10.1091/mbc.E14-01-0007.
5. Hmelevskaya V.N., Kupriyanova E.I., Cepenko V.V. Ewingʼs pelvic bone sarcoma (literature reference). A clinical case of prolonged observation of a patient after curing of Ewingʼs pelvic bone sarcoma with metastases to regional lymph nodes and to the right lung. Sarkomy kostey, myagkikh tkaney i opukholi kozhi = Sarcomas of Bones, Soft Tissues and Skin Tumors 2019;1:34–5. (In Russ.).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献